Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins

Invention Grant

US10010498B2 Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins 有权

Patent Title: Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins
Application No.: US15075051

Application Date: 2016-03-18
Publication No.: US10010498B2

Publication Date: 2018-07-03
Inventor: Ravindra Kumar , Asya Grinberg
Applicant: Acceleron Pharma Inc.
Applicant Address: US MA Cambridge
Assignee: ACCELERON PHARMA INC.
Current Assignee: ACCELERON PHARMA INC.
Current Assignee Address: US MA Cambridge
Agency: White & Case LLP
Main IPC: A61P21/06
IPC: A61P21/06 ; A61K38/17 ; C07K14/47 ; A61K9/00 ; C07K19/00 ; A61K38/00

Abstract:

The disclosure provides, in part, follistatin polypeptides that are suitable for use in local administration and methods for use.

Public/Granted literature

Information query

Espacenet

IPC分类: